Stuck in a cycle of unexplained blisters and itching that won't heal? It could be this rare condition.
(BPT) - Key takeaways:
- Intense, unrelenting itchiness, potential blisters and rashes may be a sign of bullous pemphigoid (BP), a rare autoimmune skin condition.
- BP is often misdiagnosed, making the condition harder to treat and leaving patients without relief.
- For years, patients had limited treatment options, but there is an option with the first and only approved biologic treatment that targets a key source of underlying inflammation that may contribute to BP.
Imagine an itch so intense with no relief that it disrupts your sleep, sometimes accompanied by painful blisters that won't heal. Symptoms that disappear only to return again. All of these are key signs and symptoms of bullous pemphigoid, a rare skin condition that's often misdiagnosed.
Bullous pemphigoid (or BP) is a chronic, relapsing autoimmune skin condition characterized by fluid-filled blisters and other inflammatory lesions.
While anyone can develop BP, it most commonly affects people over 60. BP is attributed to features of type 2 inflammation, an overactive immune response in your body. The condition occurs when a person's immune system mistakenly attacks a healthy layer of skin tissue. Outbreaks can be triggered by certain medications, but the reason why this happens is not fully understood.
According to practicing dermatologist Erin Xiaolu Barrett, MD, MBA, FAAD, Professor and Chair, Department of Dermatology, University of Nebraska at Omaha, "A BP patient is usually older, suffering from an unrelenting itch that might be accompanied by a rash or happen on its own. The itch they describe is mind-numbing. Some of my patients have reported that the itching can last for more than six hours a day, leading to a disruption to their daily activities and sleep."
Recognizing the signs of BP
While BP affects people differently, there are some common symptoms and signs:
- Intense itching, with or without lesions
- Itchy blisters on normal-appearing or red skin
- Scabs and/or open sores that may bleed
While blisters may appear anywhere, they commonly form near creases in the skin such as the armpits, groin and thighs, or neck. BP can go away on its own, but it often returns, subjecting patients to a constant cycle of flare-ups. Left untreated, a patient may experience these symptoms for months, if not years.
The diagnostic puzzle of BP
"BP is one of the great mimickers because it looks like many other skin conditions," said Barrett. "It can present with the classic blistering, but can also appear as a rash, hives, eczema or small raised bumps. While blistering is the most recognizable symptom of BP, some patients may also present with no blistering, which tends to delay diagnosis and they suffer for much longer as a result."
These challenges can lead to patients being diagnosed with other skin conditions and prescribed therapies that may not be appropriate. Delays in diagnosis can lead to later treatment that may increase risk of complications, including infections and hospitalizations.
Working with a dermatologist can help patients reach the right diagnosis and identify the appropriate treatment to treat the recurring signs and symptoms.
Another approach to treating BP
The goal of finding a treatment option for BP is to relieve itching and pain, help prevent new blisters from forming, and allow the skin to heal.
Patients with BP have had limited treatment options, with most relying on topical creams or oral corticosteroids, antibiotics and immunosuppressants. "Since many patients with BP are also older with other health conditions, treatment decisions become more critical and complex," Barrett added.
In 2025, the FDA approved DUPIXENT® (dupilumab) as the first and only prescription medicine for the treatment of BP in patients aged 18 and older. Dupixent targets a key source of underlying inflammation that may contribute to BP. It helps to treat the signs and symptoms from an inside-out approach.
"I've been practicing long enough to remember a time when we had a very limited arsenal for treating type 2 inflammatory diseases such as BP," said Barrett. "Dupixent works continuously to help people with BP stay ahead of signs and symptoms, offering another option for patients who are stuck in a cycle of flare-ups and relapses."
Dupixent was studied in a 52-week trial with 106 adults with BP. Over the course of the trial, some patients on Dupixent achieved sustained remission, which means there are no new blisters, old ones are healing, and steroids are tapered off by Week 16, with no relapses from Week 16 to Week 36, and no rescue treatment through Week 36. At 36 weeks, more patients had sustained remission (18% on DUPIXENT vs 6% on placebo), experienced less itch (38% on DUPIXENT vs 11% on placebo), and less total amount of oral steroids used (2.8 g for patients on DUPIXENT vs 4.1 g on placebo). This analysis was not statistically significant. Definitive conclusions cannot be made for these results. Individual results may vary.
The most common side effects include joint pain (arthralgia), eye problems (including inflammation of the eyes and eyelids, redness, swelling, itching, and blurred vision), and herpes virus infections. Please see additional safety information below.
Dr. Barrett shared that, "For many of my patients with BP, relief from blisters and relentless itching has made a real difference."
Start the conversation
If you believe you or someone you know is suffering from BP, it's important to start a conversation with your healthcare provider.
Timely diagnosis and appropriate treatment can help manage symptoms and reduce the risk of severe outcomes.
To learn more about BP and if Dupixent (dupilumab) may be right for you, visit Dupixent.com.
IMPORTANT SAFETY INFORMATION & INDICATION
Do not useif you are allergic to dupilumab or to any of the ingredients in DUPIXENT®.
Before using DUPIXENT, tell your healthcare provider about all your medical conditions, including if you:
- have eye problems.
- have a parasitic (helminth) infection.
- are scheduled to receive any vaccinations. You should not receive a "live vaccine" right before and during treatment with DUPIXENT.
- are pregnant or plan to become pregnant. It is not known whether DUPIXENT will harm your unborn baby.
- A pregnancy registry for women who take DUPIXENT during pregnancy collects information about the health of you and your baby.
- are breastfeeding or plan to breastfeed. It is not known whether DUPIXENT passes into your breast milk.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Especially tell your healthcare provider if you are taking oral, topical, or inhaled corticosteroid medicines or if you have BP and asthma and use an asthma medicine. Do not change or stop your other medicines, including corticosteroid medicine or other asthma medicine, without talking to your healthcare provider. This may cause other symptoms that were controlled by those medicines to come back.
DUPIXENT can cause serious side effects, including:
- Allergic reactions. DUPIXENT can cause allergic reactions, including skin reactions, that can sometimes be severe. Stop using DUPIXENT and tell your healthcare provider or get emergency help right away if you get any of the following signs or symptoms: breathing problems or wheezing, swelling of the face, lips, mouth, tongue, or throat, fainting, dizziness, feeling lightheaded, fast pulse, fever, hives, skin rash, including rash that looks like a bullseye, painful red or blue bumps under the skin, or red pus-filled spots on the skin, general ill feeling, itching, swollen lymph nodes, nausea or vomiting, joint pain, or cramps in your stomach area.
- Eye problems.Tell your healthcare provider right away if you have any new or worsening eye problems, including eye pain or changes in vision, such as blurred vision. Your healthcare provider may send you to an ophthalmologist for an eye exam if needed.
- Joint aches and pain. Some people who use DUPIXENT have had trouble walking or moving due to their joint symptoms, and in some cases needed to be hospitalized. Tell your healthcare provider about any new or worsening joint symptoms. Your healthcare provider may stop DUPIXENT if you develop joint symptoms.
The most common side effects in patients with bullous pemphigoid include joint pain (arthralgia); eye problems, including eye and eyelid inflammation, redness, swelling, itching, and blurred vision; and herpes virus infections.
Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of DUPIXENT. Call your doctor for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Use DUPIXENT exactly as prescribed by your healthcare provider. It's an injection given under the skin (subcutaneous injection). Your healthcare provider will decide if you or your caregiver can inject DUPIXENT. Do not try to prepare and inject DUPIXENT until you or your caregiver have been trained by your healthcare provider.
Please see accompanying fullPrescribing Information includingPatient Information.
INDICATION
DUPIXENT is a prescription medicine used to treat adults with bullous pemphigoid (BP). It is not known if DUPIXENT is safe and effective in children with BP under 18 years of age.
US.DUP.26.09.0075 10/26
Source: BrandPoint











